SCHEMBL4967601

SCHEMBL4967601

CC[N+](C)(CC)C1Cc2cc(F)cc(-c3ccccc3Cl)c2O1

nearest known ligand 0.47

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
AQP1 P29972 3/20 0.47
HTR1A P08908 4/20 0.32
HTR7 P34969 4/20 0.32
CNR1 P21554 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4830774 0.87 AQP1 (0.50) AQP1
SCHEMBL4791163 0.84 AQP1 (0.36) AQP1HTR7
SCHEMBL4974465 0.84 MAPK14 (0.37)
SCHEMBL4968821 0.81 AQP1 (0.38) AQP1CNR1
SCHEMBL4765146 0.79 AQP1 (0.50) AQP1HTR1AHTR7CNR1
SCHEMBL4765139 0.76 AQP1 (0.49) AQP1HTR1AHTR7CNR1
SCHEMBL4228615 0.76 AQP1 (0.58) AQP1CNR1
SCHEMBL4222332 0.76 AQP1 (0.76) AQP1CNR1
SCHEMBL4228623 0.76 AQP1 (0.58) AQP1CNR1
SCHEMBL4224838 0.75 AQP1 (0.79) AQP1HTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879569-A2 THERAPEUTIC COMBINATIONS FOR THE TREATMENT OR PREVENTION OF PSYCHOTIC DISORDERS Wyeth (US) 2008-01-23 EP disclosed
WO-2006116221-A2 THERAPEUTIC COMBINATIONS FOR THE TREATMENT OR PREVENTION OF PSYCHOTIC DISORDERS WYETH (US) 2006-11-02 WO disclosed